PMS2 and ovarian carcinoma: MSI can be due to germline mutation within at least one of four mismatch repair genes (MLH1, MSH2, MSH6, and PMS2), but more likely to hypermethylation of the MLH1 promoter in sporadic cancers, including ovarian cancers, with an occurrence of 37.5% [39].